Clinical Trial Update: Bioavailability of EPA and DHA From Two Dietary Supplements [NA]

View source ↗

Summary

This clinical trial update reports on the bioavailability of EPA and DHA from two dietary supplements in adults with hypertriglyceridemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• EPA/DHA dietary supplement A (eicosapentaenoic acid; docosahexaenoic acid)
• EPA/DHA dietary supplement B (eicosapentaenoic acid; docosahexaenoic acid)

Snippet

Sponsor: Arctic Nutrition AS | Conditions: Hypertriglyceridemia | NA | Status: UNKNOWN